Development of Molecular Biologic Diagnostic and Therapeutic Method of Asymptomatic Myocardial Ischemia and Unstable Angina
Development of Molecular Biologic Diagnostic and Therapeutic Method of Asymptomatic Myocardial Ischemia and Unstable Angina
批准号:
07557231
负责人:
SEKO Yoshinori
金额:
$1.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1997
中文摘要
点击翻译按钮获取中文摘要
英文摘要
1. Molecular mechanism of cardiac adaptation to hypoxia/re oxygenation : We showed that hypoxia/re oxygenation activated Src family tyrosine kinases, p2l^<TAS>, three MAPK family member kinases and their upstream as well as downstream kinases, Jak/STAT tyro sine kinases, and a transcription factor ATF-2. The signal transduction cascades activated by these stimuli were at least partly different. 2. Autocrine mechanism via certain humoral factors involved in the activation of intracellular signaling induced by hypoxia/re oxygenation : (A) We showed that the activation of intracellular signaling in cardiac myocytes induced by hypoxia was mediated by VEGF in an auto crine fashion. (B) We found that similar autocrine mechanism was involved in the activation of intracellular signaling in cardiac myocytes induced by reoxygenation, and we are now isolating and purifying the humoral factor. 3. Sensitive detection of hypoxia/re oxygenation in the heart of patients with angina pectoris and acute myocardial infarction : (A) By measuring the serum levels of VEGF in patients with acute myocardial infarction undergoing early reperfusion therapy, we demonstrated that VEGF could be a sensitive indicator of ischemic (hypoxic) state. This also strongly supported the data of 2. (A). (B) We are now isolating and purifying the humoral factor involved in the activation of intracellular signaling induced by reoxygenation, and we suppose that the serum levels of the humaral factor will be a good indicator of reperfused (reoxygenated) state in the heart of these patients. 4. Anti-cell-adhesion molecule therapy against myocardial ischemia/reperfusion injury : We demonstrated using a rat model that in vivo administration of selectin oligopeptide or anti-sialy-Lewis^x mAb significantly reduced myocardial ischemia/reperfusion injury.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Seko Y,Tobe K,Takahashi N,Kaburagi Y,Kadowaki T,Yazaki Y: "Hypoxia and hypoxia/reoxygenation activate src family tyrosine kinases and p21^<ras> in cultured rat cardiac myocytes." Biochem Biophys Res Commun. 226. 530-535 (1996)
Seko Y、Tobe K、Takahashi N、Kaburagi Y、Kadowaki T、Yazaki Y:“缺氧和缺氧/复氧激活培养的大鼠心肌细胞中的 src 家族酪氨酸激酶和 p21^<ras>。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Seko Y,Tobe K,Ueki K,Kadowaki T,Yazaki Y: "Hypoxia and hypoxia/reoxygenation activate Raf-1, mitogen-activated protein (MAP) kinase kinase, MAP kinases, and S6 kinase in cultured rat cardiac myocytes." Circ Res. 78. 82-90 (1996)
Seko Y、Tobe K、Ueki K、Kadowaki T、Yazaki Y:“缺氧和缺氧/复氧会激活培养的大鼠心肌细胞中的 Raf-1、丝裂原激活蛋白 (MAP) 激酶激酶、MAP 激酶和 S6 激酶。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Seko Y,Enokawa Y,Tamatani T,Kannagi R,Yagita H,Okumura K,Yazaki Y: "Expression of sialyl Lewis^x in rat heart with ischemia/reperfusion and reduction of myocardial reperfusion injury by a monoclonal antibody against sialyl Lewis^x." J Pathol. 180. 305-310
Seko Y、Enokawa Y、Tamatani T、Kannagi R、Yagita H、Okumura K、Yazaki Y:“唾液酸 Lewis^x 在缺血/再灌注大鼠心脏中的表达,并通过针对唾液酸 Lewis^x 的单克隆抗体减少心肌再灌注损伤
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Seko, Y.,et al.: "Restricted Usage of T-cell receptor Vα-Vβ genes in infiltrating cells in the hearts of patients with acute myocarditis……" J. Clin. Invest.96. 1035-1041 (1995)
Seko, Y. 等人:“急性心肌炎患者心脏浸润细胞中 T 细胞受体 Vα-Vβ 基因的限制使用……”J. Clin. 1035-1041 (1995)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Seko, Y., et al.: "Perforin-positive leukemic cell infiltration in the heart of a patient with T-cell prolymphocytic leukemia." Intern. Med.34. 782-784 (1995)
Seko, Y. 等人:“T 细胞幼淋巴细胞白血病患者心脏中穿孔素阳性白血病细胞浸润。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 13 条
Identification of the Receptor for ORAIP That Mediates Cardiac Response to Oxidative Stresses and Development of Treatment
-
批准号:15390240
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.32万
-
财政年份:2003
-
负责人:SEKO Yoshinori
-
依托单位:
Identification of the ligands for Cardiac Orphan G protein -Coupled Receptors and Development of T herapy Modulating Cardiac Function
-
批准号:13470140
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.96万
-
财政年份:2001
-
负责人:SEKO Yoshinori
-
依托单位:
Purification and Identification of the Bioactive Subs tance That Mediates Cardiac Response to the Ischemia Reperfusion Stresses and Development of Treatment
-
批准号:11470158
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$9.54万
-
财政年份:1999
-
负责人:SEKO Yoshinori
-
依托单位:
Development of the Specific Immunotherapy for Myocarditis, Dilated Cardiomyopathy(Chronic Myocarditis), and Takayasu Arteritis.
-
批准号:11557048
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$8.64万
-
财政年份:1999
-
负责人:SEKO Yoshinori
-
依托单位:
Elucidation of the Molecular Mechanism of Cardiac Response to the Ischemia Reperfusion Stresses and Establishment of Treatment Based on the Molecular Mechanism
-
批准号:09470162
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.6万
-
财政年份:1997
-
负责人:SEKO Yoshinori
-
依托单位:
国内基金
海外基金
登录
查看更多内容
缺氧诱导因子(HIF)-2α转录抑制树突状细胞CD36表达减轻肾脏缺血再灌注损伤的机制
-
批准号:82370751
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:张明
-
依托单位:
骨髓抑制再生单个核细胞移植通过调节线粒体功能在脑缺血再灌注损伤中的神经保护机制研究
-
批准号:82371301
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:李轶
-
依托单位:
TRIM21蛋白促进HIF1α的降解介导耳蜗血管纹缘细胞缺血再灌注致听力损伤的机制研究
-
批准号:82371142
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘君
-
依托单位:
肢体缺血后适应抑制肺泡巨噬细胞活化及防治肺缺血再灌注损伤机制的研究
-
批准号:81070041
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:甘辉立
-
依托单位: